ResMed is integrating its leading consumer app myAir™ with Apple and Android smartwatches to help people manage their sleep health and maintain CPAP treatment (with continuous positive airway pressure). facilitate. Introducing a generative AI-enabled sleep health assistant that helps people sleep better while on the road, and new travel gear that helps people maintain their CPAP treatment while traveling.
SAN DIEGO, Sept. 30, 2024 (Globe Newswire) — ResMed (NYSE: RMD, ASX: RMD), the world’s leading health technology company focused on sleep, breathing and home care, today announced that We have announced a new core product. A product designed to enhance the treatment process for sleep apnea patients. These innovations are integrated with digital wearable devices and generative artificial intelligence designed to provide a more personalized sleep health experience and improve overall health.
ResMed’s 2024 Global Sleep Survey found that 44% of Americans get less than three days of adequate sleep per week, significantly impacting their quality of life. The growing popularity of digital wearables such as smartwatches and health trackers has given individuals access to data-driven insights and the ability to actively participate in improving their health. Sleep health has become a key focus in this evolving landscape, with more than half (54%) of respondents in a recent ResMed survey expressing interest in purchasing a wearable device with sleep tracking capabilities.
Digital wearables give consumers instant access to sleep and other important health insights, giving them valuable information to work with their healthcare providers. ResMed’s latest innovations are designed with users at the forefront, providing personalized insights into sleep patterns and flexibility that allow people to stay on track with their sleep therapy no matter what life throws at them. Provide.
New patient engagement features in ResMed myAir app designed to help people take control of their health
ResMed myAir is an intuitive app that allows patients to continuously participate in their CPAP therapy, leading to improved health outcomes. With interactive coaching and the ability to track nightly sleep data, myAir led to significant increases in CPAP usage and 87% of patients achieved treatment compliance1.
New myAir patient engagement features include:
myAir smartwatch app: Now available for Apple and Android smartwatches. This app allows users to monitor treatment data at a glance, making it easier to continue with CPAP therapy. Sleep Staging: Integrates sleep stage data (wake, REM, core, sleep). integrate Apple Health and Health Connect from deep) into myAir, giving users a clearer understanding of their entire sleep cycle. Personalized Coaching: Provides customized tips and strategies based on behavioral science and machine learning to help users stay on track with their CPAP therapy through personalized support. Comprehensive trends: Helps users by providing data such as tracked steps, energy expended, weight, blood oxygen, BMI, daily exercise, heart rate variability, resting heart rate, bedtime, total sleep time, etc. You can get a comprehensive understanding of your health status. , all your CPAP treatment data from Apple Health and Health Connect in one place.
“We know that innovative technologies like digital wearables and AI can help consumers better understand their sleep habits and create personalized pathways to better rest. ” said Carlos M. Nunez, M.D., Chief Medical Officer of ResMed. “Tracking sleep regularly provides important insights that can help people make informed decisions about improving their sleep quality now and in the future.”
Introducing Dawn: A generative AI-enabled sleep health concierge
Dawn, ResMed’s new AI-enabled health concierge, is changing the way people learn about sleep apnea. Dawn provides instant access 24/7 to many answers about sleep health, ResMed products, and CPAP therapy support. Dawn uses Generative AI to provide personalized guidance and provide users with the information they need in real time.
LUXE, travel gear thoughtfully designed for CPAP users
To cater to frequent travelers with an eye for sophisticated design, ResMed has introduced the LUXE series of tote bags and backpacks. A stylish and practical travel bag designed to make it easier to continue your CPAP therapy while on the move. LUXE includes a modular insert to safely transport your AirSense™ 10/11 or AirMini™, mask, tubing, and power supply. It will be available in limited quantities from October 28th through shop.ResMed.com (US), shop.ResMed.com.au (AU), and the Tmall platform (China).
To learn more about ResMed’s latest innovations and new products, visit ResMed.com/ProductUpdate.
Android is a trademark of Google LLC. Apple® is a registered trademark of Apple, Inc.
About ResMed
At ResMed (NYSE: RMD, ASX: RMD), we pioneer innovative solutions that treat people to keep them out of hospital and help them live healthier, higher-quality lives. Our digital health technology and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic conditions. Our comprehensive out-of-hospital software platform supports professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and health systems in more than 140 countries. For more information, visit ResMed.com and follow @ResMed.
For media:
Rebecca Ehlinger-Janson
(760) 496-8320
news@resmed.com
team lewis
ResMedUS@teamlewis.com
For investors:
+1 858.836.5000
investorrelations@resmed.com
1 Malhotra A et al. Patient engagement using new technology to improve adherence to positive airway pressure therapy: A retrospective analysis. chest. 2018;153:843–850. doi:10.1016/j.chest.2017.11.005.
Photos accompanying this announcement are available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/feecab13-d2b5-4163-a35f-f161d2265c94
https://www.globenewswire.com/NewsRoom/AttachmentNg/580c3d1e-5d5d-4df1-bce7-26f32ec58b1d
https://www.globenewswire.com/NewsRoom/AttachmentNg/dbdf99ca-a395-4bad-a5e8-9dac14797796
